online

Michael Böhm - About the Symplicity HTN-3 press release

Michael Böhm (Germany) answers the following questions:

- How does the Symplicity HTN-3 update affect your work? Do you continue renal denervation?

- Further indications for renal denervation?

- Can you please summarise the main points of the ReAdapt CHF trial?

Privacy-policy

Thank you for visiting ResistantHypertensionCourse.com website. We respect your privacy and consider it an important element of our business. Our privacy policy is straightforward: We do not collect personal information about you when you visit our website unless you volunteer to provide that information to us.

This is broadly how we handle the information we gather.

Information collected and stored automatically

L'hypertension artérielle aux JESFC 2014

Le professeur Atul Pathak partage avec ses confrères francophones les principales recommandations de traitement de l'hypertension artérielle.

 

Highlights on hypertension at the JESFC 2014

Highlights on hypertension at the JESFC 2014

   

 

Typography

H1 Heading

Pellentesque pellentesque eget tempor tellus. Fusce lacllentesque eget tempor tellus ellentesque pelleinia tempor malesuada. Pellentesque pellentesque eget tempor tellus ellentesque pellentesque eget tempor tellus. Fusce lacinia tempor malesuada.

H2 Heading

Pellentesque pellentesque usce lacllentesque eget tempor tellus ellentesque pelleinia tempor malesuada. Pellentesque pellentesque eget tempor tellus ellentesque pellentesque eget tempor tellus. tellus eget tempor. Fusce lacinia tempor malesuada.

L'hypertension artérielle aux JESFC 2014.

À l'occasion des 24èmes Journées Européennes de la Société Française de Cardiologie du 15 au 18 janvier 2014, le Pr Pathak revient sur les trois informations principales discutées en conférence...

Pages